Can a gas added to Heart-Lung machines shield Newborns' kidneys?

NCT ID NCT04216927

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether adding nitric oxide gas to the heart-lung machine during surgery can prevent acute kidney injury in newborns with congenital heart defects. Up to 60% of these babies experience kidney damage after surgery, which can lead to serious complications. The study will compare babies who receive nitric oxide during bypass with those who receive oxygen alone, monitoring for signs of kidney injury in the first 72 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nitric oxide gas administered during cardiopulmonary bypass
What this could lead to
If effective, this simple addition to bypass could prevent acute kidney injury in newborns after heart surgery, reducing complications and improving recovery.
What could go wrong
This is a small, early-phase trial, and the benefit is not yet proven. Nitric oxide may not reduce kidney injury, and there are always risks with any intervention in fragile neonates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AKI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cincinnati Children's Hospital Medical Center

    RECRUITING

    Cincinnati, Ohio, 45229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.